Literature DB >> 21827935

Use of complementary and alternative medicine among USA adults with functional limitations: for treatment or general use?

Catherine A Okoro1, Guixiang Zhao, Chaoyang Li, Lina S Balluz.   

Abstract

OBJECTIVES: This study compared the use of complementary and alternative medicine (CAM) to treat health conditions with CAM use for general wellness or disease prevention among USA adults with and without functional limitations.
DESIGN: This was a cross-sectional survey.
METHODS: Data were obtained from the 2007 U.S. National Health Interview Survey (n=20,710).
RESULTS: Overall use of CAM treatment was higher among adults with functional limitations than among those without (61.4% versus 41.8%; p<0.001). Adults with functional limitations were more likely to use 3 of 4 CAM groupings: biologically based therapies (BBT) (47.9% versus 29.5%, p<0.001), manipulative and body-based therapies (73.7% versus 54.1%, p<0.001), and mind-body therapies (MBT) (39.3% versus 17.4%, p<0.001). Use of alternative medical systems for treatment was highly prevalent among adults (86.9% versus 80.0%, p=0.06), regardless of functional status. Adults with functional limitations were as likely to use CAM to treat the condition underlying their functioning difficulty (48.7%) as they were to treat other conditions (51.3%). Massage therapy was used most often to treat conditions that limited functional ability (53.4%). Older age was a predictor of the use of BBT for treatment, whereas younger age was a predictor of the use of MBT.
CONCLUSIONS: The prevalence of CAM use for treatment of conditions is high. Public health strategies are needed to promote disclosure of CAM use to health care providers, promote increased screening for CAM use by health care providers, and promote health care interactions that facilitate communication about CAM safety and efficacy. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21827935     DOI: 10.1016/j.ctim.2011.06.003

Source DB:  PubMed          Journal:  Complement Ther Med        ISSN: 0965-2299            Impact factor:   2.446


  6 in total

1.  Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Authors:  Sarah K Nabukera; Paul A Romitti; Kimberly A Campbell; F John Meaney; Kristin M Caspers; Katherine D Mathews; Stacey M Hockett Sherlock; Soman Puzhankara; Christopher Cunniff; Charlotte M Druschel; Shree Pandya; Dennis J Matthews; Emma Ciafaloni
Journal:  J Child Neurol       Date:  2011-12-07       Impact factor: 1.987

2.  Has the use of complementary and alternative medicine therapies by U.S. adults with chronic disease-related functional limitations changed from 2002 to 2007?

Authors:  Catherine A Okoro; Guixiang Zhao; Chaoyang Li; Lina S Balluz
Journal:  J Altern Complement Med       Date:  2012-10-16       Impact factor: 2.579

3.  Effect of a brief seated massage on nursing student attitudes toward touch for comfort care.

Authors:  Paul C Turkeltaub; Edilma L Yearwood; Erika Friedmann
Journal:  J Altern Complement Med       Date:  2014-08-20       Impact factor: 2.579

4.  Yoga for People With Chronic Pain in a Community-Based Setting: A Feasibility and Pilot RCT.

Authors:  Arlene A Schmid; Christine A Fruhauf; Julia L Sharp; Marieke Van Puymbroeck; Matthew J Bair; Jennifer Dickman Portz
Journal:  J Evid Based Integr Med       Date:  2019 Jan-Dec

Review 5.  A scoping review of network meta-analyses assessing the efficacy and safety of complementary and alternative medicine interventions.

Authors:  Misty Pratt; Susan Wieland; Nadera Ahmadzai; Claire Butler; Dianna Wolfe; Kusala Pussagoda; Becky Skidmore; Argie Veroniki; Patricia Rios; Andrea C Tricco; Brian Hutton
Journal:  Syst Rev       Date:  2020-04-30

6.  Getting started with taiji: investigating students expectations and teachers appraisals of taiji beginners courses.

Authors:  Marko Nedeljkovic; Christina Bürgler; Petra H Wirtz; Roland Seiler; Konrad M Streitberger; Brigitte Ausfeld-Hafter
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.